Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Tax Rate (2019 - 2025)

Historic Tax Rate for Arrowhead Pharmaceuticals (ARWR) over the last 7 years, with Q4 2025 value amounting to 0.1%.

  • Arrowhead Pharmaceuticals' Tax Rate rose 1600.0% to 0.1% in Q4 2025 from the same period last year, while for Dec 2025 it was 8.39%, marking a year-over-year increase of 84900.0%. This contributed to the annual value of 41.56% for FY2025, which is 411100.0% up from last year.
  • Per Arrowhead Pharmaceuticals' latest filing, its Tax Rate stood at 0.1% for Q4 2025, which was up 1600.0% from 55.37% recorded in Q3 2025.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Tax Rate peaked at 55.37% during Q3 2025, and registered a low of 4.61% during Q3 2022.
  • Its 5-year average for Tax Rate is 4.25%, with a median of 0.02% in 2021.
  • Its Tax Rate has fluctuated over the past 5 years, first plummeted by -46000bps in 2022, then soared by 556900bps in 2025.
  • Quarter analysis of 5 years shows Arrowhead Pharmaceuticals' Tax Rate stood at 0.0% in 2021, then plummeted by -1189bps to 0.04% in 2022, then soared by 5973bps to 2.39% in 2023, then tumbled by -102bps to 0.06% in 2024, then surged by 274bps to 0.1% in 2025.
  • Its Tax Rate was 0.1% in Q4 2025, compared to 55.37% in Q3 2025 and 0.24% in Q2 2025.